Contract opportunity

RFI Lupus Research Program (LRP) Public

Sources Sought from Department of Defense.

Data as of Oct 24, 2026. Sources: SAM.gov and Grants.gov. Snapshot govcon-directory-20261024T104923Z-2151694.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services. Counts and totals are computed by DSE from public SAM.gov and Grants.gov notices. Text from Grants.gov may be shortened or have contact details removed. The original notice on Grants.gov is the authoritative version.

Closing in 23 days

Notice details

Agency
Department of Defense
Sub-tier agency
DEFENSE HEALTH AGENCY (DHA)
Notice type
Sources Sought
Solicitation number
HT9427RFI2027LRP
NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
Place of performance
Frederick, Maryland
Posted
Oct 16, 2026
Response deadline
Nov 16, 2026
Source
SAM.gov

Description

The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform potential future Lupus Research Program (LRP) focus areas and associated research funding opportunities. Although fiscal year 2027 (FY27) funds have not been appropriated, the LRP is requesting this information to support program planning processes. The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI is for information and planning purposes only and should not be construed as a solicitation or an obligation on the part of the LRP or the Department of War. BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP LRP�s vision is to cure lupus through partnership of scientists, clinicians and persons affected by lupus. The LRP�s mission is to fund research to understand, prevent, and diagnose lupus and to improve treatments and quality of life of patients, including Service Members and their Families, Veterans and the general public. Appropriations for the LRP from FY17-24 and FY26 totaled $75 million. As of October 2026, FY27 funds for the LRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process

Summarized from the official notice. The description is shortened; read the full text on the official notice.

Official notice

View on SAM.gov →

Requirements and amendments are controlled by the official notice.

DSE verdict

The DSE fit verdict for this notice is available to DSE GovCon subscribers. It is not published on this page.

See DSE GovCon plans →

Similar open notices

  1. NAWCWD Broad Agency AnnouncementClosing in 6 daysDEPT OF DEFENSE · Posted Dec 31, 2025 · Closes Oct 30, 2026
  2. NOTICE OF INTENT TO SOLE SOURCE for the Development of a Handheld Device for Rapid Assessment of Burn Sepsis RiskClosing in 9 daysDEPT OF DEFENSE · Posted Sep 19, 2026 · Closes Nov 2, 2026
  3. DARPA Surgical Competition (DSC) Second Industry DayClosing in 9 daysDEPT OF DEFENSE · Posted Oct 15, 2026 · Closes Nov 2, 2026
  4. High-throughput Unmasking of Biological Interactomes with Binding Landscape Emulators (HUBBLE)Closing in 12 daysDEPT OF DEFENSE · Posted Oct 9, 2026 · Closes Nov 5, 2026
  5. FirefoxClosing in 16 daysDEPT OF DEFENSE · Posted Sep 17, 2026 · Closes Nov 9, 2026

Get free alerts

Email alerts for notices like this one are free on DSE GovCon Intelligence.

Set up free alerts →

Frequently asked questions

When is the response deadline?

The published deadline is Nov 16, 2026. That is 23 days after the data date.

What NAICS code applies?

NAICS 541714, Research and Development in Biotechnology (except Nanobiotechnology).

Which agency issued this notice?

Department of Defense.

Where is the official notice?

The link under Official notice opens the source listing.